Yiying Wang

Associate

Yiying Wang represents companies, investment banks and private equity funds in IPOs in the US and Hong Kong capital markets, cross-border M&A transactions, and various other corporate transactions.

Download full bio

Experience

Asymchem Agrees to Acquire Snapdragon Chemistry
Asymchem Laboratories – HK$7.15 Billion IPO
Keymed Biosciences – HK$3.1 Billion IPO

Practices & Industries

Capital Markets
Mergers & Acquisitions
Private Equity
Life Sciences
Asia

Education

Columbia Law School
LLM
Peking University Law School
LLB

Admissions & Credentials

New York

Media & Insight

Asymchem Laboratories – HK$7.15 Billion IPO
December 15, 2021
Keymed Biosciences – HK$3.1 Billion IPO
July 8, 2021

Contact

yiying.wang@cooley.com

+86 21 6030 0660

Download vCard

Locations

Shanghai